Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes
Abstract Individuals with type 2 diabetes have an increased risk of cardiovascular disease. A correlation between plasma aldosterone and hyperinsulinemia has been demonstrated in vivo, and hyperinsulinemia and insulin resistance are independently associated with the development of cardiovascular com...
Main Authors: | Stine H. Finsen, Mie R. Hansen, Joachim Hoffmann‐Petersen, Henrik F. Højgaard, Stefan P. Mortensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.14971 |
Similar Items
-
Eight weeks of treatment with mineralocorticoid receptor blockade does not alter vascular function in individuals with and without type 2 diabetes
by: Stine H. Finsen, et al.
Published: (2024-04-01) -
Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction
by: Aderonke E. Igbekele, et al.
Published: (2022-08-01) -
Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
by: Memory MUKANGWA, et al.
Published: (2019-12-01) -
Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
by: Line Aas Mortensen, et al.
Published: (2017-11-01) -
Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
by: Luo Shi, et al.
Published: (2019-11-01)